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Abstract
Background: While a possible link between assisted reproductive technology (ART) and rare imprinting disorders
has been found, it is not clear if this is indicative of subtler disruptions of epigenetic mechanisms. Results from
previous studies have been mixed, but some methylation differences have been observed.
Methods: Children conceived through ART and children conceived spontaneously were recruited for this cross-
sectional study. Information about reproductive history, demographic factors, birth characteristics, and infertility
treatment was obtained from maternal interview and medical records. Peripheral blood lymphocytes and buccal
cell samples were collected from participating children. Methylation analysis was performed on five loci using
pyrosequencing. Statistical analysis of methylation differences was performed using linear regression with
generalized estimating equations. Results are reported as differences with 95% confidence intervals (CI).
Results: A total of 67 ART children and 31 spontaneously conceived (SC) children participated. No significant
difference in methylation in lymphocyte samples was observed between groups for any loci. Possible differences
were found in buccal cell samples for IGF2 DMR0 (Difference: 2.07; 95% confidence interval (CI): -0.28, 4.42; p =
0.08) and IGF2R (Difference: -2.79; 95% CI: -5.74, 0.16; p = 0.06). Subgroup analysis indicated potential lower
methylation in those whose parents used ART for unexplained infertility.
Conclusions: Observed differences in methylation between the ART and SC groups were small for all loci in the
two sample types examined and no statistical differences were observed. It is still unclear whether or not small
differences observed in several studies represent a real difference between groups and if this difference is
biologically meaningful. Larger studies with long term follow-up are needed to fully answer these questions.
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Background
Use of assisted reproductive technology (ART), includ-
ing in vitro fertilization (IVF) and intracytoplasmic
sperm injection (ICSI), is rapidly rising in the United
States (US) and curxxrently accounts for over one per-
cent of all infants born each year [1]. The potential for
epigenetic disruptions in children born after infertility
treatment, particularly ART, was first seen in a number
of studies showing an increase in imprinting disorders
such as Beckwith-Wiedemann syndrome (BWS), Angel-
man syndrome (AS), and Silver-Russell syndrome (SRS)
in these children [2-16]. These studies further indicated
that the cause of the imprinting disorders was due to
epigenetic disruptions rather than mutations or unipar-
ental disomy [4,5,7,9-11,13,17-20].
Imprinting disorders are very rare and, even with a
relative increase in incidence of these disorders, most
children conceived through ART are healthy. However,
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quent, but subtler disruptions of epigenetic mechanisms.
It has been suggested that such epigenetic disruptions
could potentially manifest themselves as an increased
propensity for childhood cancer as well as adult onset
diseases such as cancer and heart disease that are
thought to be epigenetically mediated [21,22].
Several recent studies have examined differences in
methylation in various imprinted gene regions after
ART in peripheral blood, placenta tissue, buccal cells,
cord blood, chorionic villus samples, and embryos
[23-38]. Results have been mixed and difficult to synthe-
size due to differences in gene regions, tissues examined,
and ways of assessing DNA methylation. However, some
studies have indicated a difference in DNA methylation
or gene expression in the various gene regions
[24,26,27,30,32,33], although other studies have not
observed a difference [25,28,29,31,34-37].
Given the mixed evidence so far, and since genes in
the 11p15 region and the IGF2R gene located at 6q26
have been associated with BWS and SRS and many dif-
ferent types of cancer, we were interested in further
exploring these regions for differential methylation. To
assess quantitative DNA methylation differences
between in children conceived after ART treatment and
children conceived spontaneously, we conducted a
cross-sectional study and focused on peripheral blood
and buccal cell samples. Specifically, we examined quan-
titative methylation values at the 11p15 region including
two CTCF binding sites within H19, one differentially
methylated region (DMR) in IGF2, and the imprinting
control region KvDMR as well as a DMR in the IGF2R
gene located at 6q26. Although some of these sites have
been commonly examined (e.g. KvDMR and CTCF
binding sites in H19), little information is available
about methylation differences in the IGF2 DMR0 and
IGF2R regions each having been explored in only one
prior study [33,38].
Methods
Study population
Two groups of children were recruited for this study;
one conceived through ART (ART group) and the other
born after spontaneous conception (SC group). ART
children had to be conceived through IVF or IVF + ICSI
with fresh non-donor oocytes. SC children had to have
been conceived without the use of any fertility drugs or
treatments. In the case of multiple births in either the
ART or SC group, only one child was selected for parti-
cipation in the study. Children diagnosed with BWS,
AS, Prader-Willi syndrome, or retinoblastoma were
excluded from the study.
ART children and their mothers were recruited from
t h eU n i v e r s i t yo fM i n n e s o ta Reproductive Medicine
Center. Mothers who conceived through ART and
reported a live birth between March 2005 and Decem-
ber 2008 were contacted about participation of their
child through a letter and follow-up phone call. Out of
328 women identified as potentially eligible, 99 agreed
to participate and 67 children completed the clinic visit.
SC children were recruited through advertisements
posted in and around the University of Minnesota. Simi-
lar to the ART children, SC children had to have been
born between March 2005 and December 2008. A total
of 45 women agreed to participate in the study and 31
children completed the clinic visit prior to the close of
the study.
This study was approved by the institutional review
board at the University of Minnesota. All mothers pro-
vided informed consent for themselves and their child
prior to participating in the study.
Sample collection
Peripheral blood lymphocytes and buccal cell samples
were collected either at a research clinic or at the parti-
cipant’s local clinic. Samples from the research clinic
were delivered for processing immediately, while other
clinic samples were sent express mail to Dr. Nelson’s
laboratory and were processed immediately upon receipt
(usually within 24 h of sample collection). Up to 6 ml of
blood was collected from each child through venipunc-
ture. Buccal cells were collected using Catch-All™ Sam-
ple Collection Swabs (Epicentre, Madison, WI, USA).
Two swabs were collected from each child.
Data collection
Information about ART and SC mothers and children
was collected through a brief questionnaire as well as
from delivery records. In addition, for ART mothers,
information on specific procedures was obtained from
medical records. The questionnaire collected demo-
graphic information, as well as maternal reproductive
history and the participating child’s birth characteristics.
All maternal and child characteristics used in the analy-
sis apart from birth weight were based on questionnaire
data. Birth weight was taken from the delivery records.
If birth weight was not available on the birth record,
maternal report from the study questionnaire was used.
SC mothers were also asked about time to pregnancy to
assess possible infertility that resolved without treat-
ment. Information obtained from infertility clinic
records included indication for infertility, number of
cycles of treatment, and specific procedure information.
Genetic regions analyzed
Three regions of interest were examined for differential
methylation: IGF2/H19, KvDMR,a n dIGF2R.T h e s e
regions were selected based on their association with
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DMR0 (3 CpGs), 3 rd (11 CpGs) and 6th (16 CpGs)
CTCF-binding site of H19 DMR, IGF2R (15 CpGs), and
KvDMR (7 CpGs). The 5th CpG cite in the 6th CTCF-
binding site of H19 DMR is known to be polymorphic
and so was excluded from the analysis [39].
Methylation analysis
Methylation analysis was performed using pyrosequen-
cing. Genomic DNA was isolated from the lymphocyte
and buccal cell samples and treated with sodium bisul-
fite using the EZ methylation kit (Zymo research). This
treatment actively changes unmethylated cytosines to
uracils while leaving methylated cytosines unchanged.
Primers and procedures for IGF DMR0,3
rd and 6
th
CTCF-binding site of H19 DMR, IGF2R were the same
as in Boissonnas, et al. [39]. The protocol for the
KvDMR region was different and based on Bourque, et
al. [40]. After PCR amplification, pyrosequencing was
performed for all regions using the PyroMark MD sys-
tem, and analyzed using the accompanying software
(Qiagen, Germantown/Gaithersburg, USA).
The percent methylation for each CpG was calculated
by taking the peak height of the methylated cytosines
divided by the sum of the peak height of the methylated
and unmethylated cytosine. Several quality assurance
tests were performed to assess the sequence generated
by the pyrosequencing reaction against the expected
sequence. CpG sites that consistently failed quality
assurance tests were excluded from the analysis. We
excluded one CpG site from H19 CTCF3, one CpG site
from H19 CTCF6 and six CpG sites from IGF2R due to
quality and polymorphism issues. Two children were
excluded in locus-specific analysis due to unexpected
sequences, likely due to polymorphisms, one in the
KvDMR locus and the other in the IGF2 DMR0 locus.
To assess the reliability of the methylation assays, we
obtained lymphocyte and buccal cell samples on nine
healthy adults. Samples were split and processed on dif-
ferent days for three loci (KvDMR, H19 CTCF3,a n d
IGF2R). Reliability was assessed using an intraclass cor-
relation coefficient (ICC). While there were a few low
ICC values for individual CpG sites, most of the sites
had high ICC values (Additional file 2). We found that
there was poor reliability for methylation analysis over
amplifications for the KvDMR region in lymphocyte
samples (ICC median (Interquartile range (IQR)): 0.54
(0.44-0.56)). However, this lower reliability was due to
an overall lower methylation level for one of the three
amplifications. Since a linear transformation of one of
the three amplifications greatly improved reliability (ICC
median (IQR): 0.78 (0.62-0.81)) accounting for amplifi-
cation in our analysis will adjust our data for possible
similar discrepancies. Reliability was goo d for the
KvDMR region in buccal samples with all individual
CpG sites found to have an ICC greater than 0.7 (ICC
median (IQR): 0.87 (0.84-0.87)). The H19 CTCF3 region
had good reliability for both buccal cells (ICC median
(IQR): 0.73 (0.66-0.77)) and lymphocytes (ICC median
(IQR): 0.76 (0.73-0.81)). The IGF2R region also had
good reliability for both buccal cells (ICC median (IQR):
0.78 (0.59-0.81)) and lymphocytes (ICC median (IQR):
0.88 (0.70-0.89)).
Data analysis
Descriptive data were compared between the two groups
using Fisher’s exact tests for categorical variables, and t-
tests for continuous variables. Differences in methylation
between groups were analyzed using linear models with
generalized estimating equations (GEE). The GEE model
accounts for the correlation between CpG cites within
an individual. Each locus was considered separately.
Adjusted models were constructed using variables
related to use of ART: maternal age (continuous),
maternal education (some college or less, college gradu-
ate, advanced degree), household income (< $40,000,
$40,000-$79,999, ≥ $80,000) and child’sb i r t hw e i g h t
(continuous); and variables possibly associated with
methylation: child’s age (continuous) and sex (male,
female). All models also included a variable indicating
day of the pyrosequencing run to control for any ampli-
fication effects. Subgroup analysis was performed within
the ART group to examine differences in methylation
by type of infertility (female only, male only, both male
and female, unexplained). Results are reported as group
means and 95% confidence intervals (CI) for the differ-
ence between groups. Sensitivity analysis was performed
excluding the samples that were rerun after assay failure.
All analysis was performed using SAS 9.2 (SAS Institute,
Inc, Cary, NC).
Results
A total of 67 children were included in the ART group
and 31 in the SC group. Of these, 53 ART children and
27 SC children provided a blood sample while 67 ART
children and 30 SC children provided a buccal cell sam-
ple. Demographic factors of the two groups are pre-
sented in Table 1. Many factors were different between
the two groups, with the ART group tending to have
higher household income, increased maternal age, and
greater frequency of multiple births. Children in the
ART group tended to be younger and have lower birth
weights.
Medical records for infertility treatment could not be
obtained for six women, leaving 61 subjects for analysis
of specific infertility diagnoses. Infertility diagnoses were
fairly equally divided between female factor only (n =
21, 34%), male factor only (n = 17, 28%), and both male
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tion for infertility was found in 10% (n = 6) of couples
and one couple was seeking treatment for reasons other
than fertility. Most couples used ICSI for at least some
of the embryos (84%) and over 70% had two embryos
transferred.
No large differences in methylation were found
between the ART and SC groups in either lymphocyte
or buccal cell samples. Table 2 displays the average
differences and 95% CI for the adjusted models. A possi-
ble, but statistically non-significant difference was seen
in buccal cells only at IGF2 DMR0, with the ART group
having higher methylation levels compared to the SC
group (Difference: 2.07; 95% CI: -0.28, 4.42; p = 0.08).
Larger, but non-significant, differences were also
observed for the IGF2R region; for both buccal cells
(Difference: -2.79; 95% CI: -5.74, 0.16; p = 0.06) and
lymphocytes (Difference: -4.41; 95% CI: -9.49, 0.66; p =
0.09) there was an indication of lower levels of methyla-
tion in the ART group. Estimates were similar when
limited to those samples that were not rerun due to
assay failure (data not shown).
In the subgroup analysis, couples with unexplained
infertility had children that tended to have lower methy-
lation levels compared with couples in which both part-
ners had an identified cause of infertility (Table 3).
Sample size was small, however, and no overall group
comparison was statistically significant.
Discussion
Overall, there was little difference in methylation
between children conceived through ART and children
conceived spontaneously. In subgroup analysis, couples
with unexplained infertility tended to have lower methy-
lation levels compared to couples in which both part-
ners had an identified cause of infertility.
The observed differences in methylation between the
ART and SC group were very small, indicating that our
failure to detect moderate differences was not due to a
lack of statistical power even though variability was
increased due to the small sample size and imperfect
assay reliability [41]. Larger samples or samples with
increased reliability could be used to detect smaller dif-
ferences; however, we were able to rule out differences
in methylation greater than about 7% in all analysis. For
lymphocyte samples, average differences were around
1% or less between groups. Based on the variability of
the samples, our analysis suggested that differences
greater than 2-4 percentage points for all loci except
IGF2R are unlikely. Methylation in buccal cell samples
was more variable, with an average difference of around
2%. For these samples, differences greater than 5-7 per-
centage points appeared unlikely. It should be noted
that it is unknown if very small differences in methyla-
tion can lead to difference in gene expression levels; so,
although it seems unlikely that there is an effect for a
few percentage points difference in methylation, it is
possible. One study did find that small differences in
DNA methylation resulted in differences in transcript
levels, suggesting that these small differences could be
biologically relevant [26].
Other studies have examined differential methylation
in various tissues of children conceived through ART
Table 1 Descriptive statistics by study group
Variable ART group
n=6 7
SC group
n=3 1
a
P-value
Maternal Characteristics n (%) n (%)
Race
White 64 (95.5) 27 (90.0) 0.37
b
Non-white 3 (4.5) 3 (10.0)
Education
< College degree 10 (14.9) 10 (33.3) 0.10
b
College degree 26 (38.8) 11 (36.7)
Advanced degree 31 (46.3) 9 (30.0)
Household income
< 40 K 4 (6.0) 7 (23.3) 0.02
b
40 K- < 80 K 18 (26.9) 10 (33.3)
80 K + 45 (67.2) 13 (43.3)
Age at child’s birth
Mean (SD) 34.1 (3.9) 29.6 (4.3) < 0.001
c
Time to pregnancy
Not trying 9 (31.0)
< 12 months 18 (62.1)
≥ 12 months 2 (6.9)
Child Characteristics n (%) n (%)
Sex
Female 32 (47.8) 13 (43.3) 0.83
b
Male 35 (52.2) 17 (56.7)
Plurality
Singleton 44 (65.7) 30 (100.0) < 0.001
b
Twins+ 23 (34.3) 0 (0.0)
Year of birth
2005 7 (10.4) 9 (30.0) 0.11
b
2006 23 (34.3) 8 (26.7)
2007 23 (34.3) 10 (33.3)
2008 14 (20.9) 3 (10.0)
Birth weight (grams)
mean (SD) 3005.57 (790.9) 3458.1 (701.9) 0.008
c
Age (years)
mean (SD) 2.5 (0.97) 3.0 (1.00) 0.02
c
a One mother did not fill out the questionnaire and is missing all responses
b Fisher’s exact test
c Two-sample t-test
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cant differences between groups, such as those seen in
our study, have been observed in many studies (Addi-
tional file 1). The most common region that has been
examined is the IGF2/H19 imprinting region. In pla-
centa tissue, two studies have indicated a potential dif-
ference in methylation and expression in H19 and IGF2
[33] and expression only in H19 but not IGF2 [30] while
another study found no difference in methylation [34].
Two studies examined possible difference in this region
in miscarriages, abortions, and stillbirths with one find-
ing a possible difference but more extreme values in the
control group [35] and the other finding six cases with
hypomethylation in the ART group and none in the
control group [27]. In addition, a study on embryos
from ART patients found that close to 19% of these
embryos had hypomethylation or demethylation in the
H19 DMR [23]. Overall, there is some evidence for pos-
sible hypomethylation or reduced methylation in chil-
dren conceived through ART in several studies
Table 2 Adjusted regression model results
Gene region of interest ART group SC group Difference
Estimate
c
95% CI p-value
N
a Mean
b N
a Mean
b
Lymphocyte samples
KvDMR 52 47.61 27 47.53 0.72 (-1.00, 2.45) 0.41
H19 CTCF3 53 42.16 27 41.70 0.66 (-0.94, 2.25) 0.42
H19 CTCF6 52 38.07 27 35.15 0.93 (-1.79, 3.65) 0.50
IGF2DMR0 53 50.04 26 48.32 0.08 (-1.82, 1.98) 0.94
IGF2R 52 69.26 27 72.13 -4.41 (-9.49, 0.66) 0.09
Buccal samples
KvDMR 64 53.46 29 52.60 1.60 (-2.77, 5.98) 0.47
H19 CTCF3 65 42.94 29 43.09 -0.24 (-2.96, 2.48) 0.86
H19 CTCF6 65 38.37 28 37.48 1.38 (-2.89, 5.64) 0.53
IGF2DMR0 65 36.52 27 35.03 2.07 (-0.28, 4.42) 0.08
IGF2R 65 79.45 29 81.35 -2.79 (-5.74, 0.16) 0.06
a Number of subjects included in the analysis
b The reported mean is averaged over all CpG sites in the region of interest
c Adjusted for pyrosequencing run, child’s age, child’s birth weight, child’s sex, maternal age, maternal education, and household income
Table 3 Adjusted regression model results by infertility diagnosis
Gene region of interest Female vs. Both
a Male vs. Both
a Unexp vs. Both
a Group
comparison
p-value
Difference
b (95% CI) Difference
b (95% CI) Difference
b (95% CI)
Lymphocyte samples
KvDMR 0.03 (-1.75,1.81) -0.21 (-2.84, 2.43) -2.71 (-6.40, 0.98) 0.51
H19 CTCF3 -0.96 (-2.96, 1.05) -1.10 (-3.26, 1.06) -2.62 (-5.99, 0.76) 0.56
H19 CTCF6 -0.89 (-3.82, 2.04) 1.01 (-2.68, 4.71) -1.98 (-8.61, 4.66) 0.72
IGF2DMR0 -1.26 (-3.24, 0.71) -1.03 (-3.59, 1.53) -3.45 (-6.87,-0.04) 0.40
IGF2R 0.43 (-4.02, 4.88) -3.40 (-7.48, 0.67) -5.92 (-13.06, 1.22) 0.39
Buccal samples
KvDMR -5.50 (-10.86,-0.15) -4.03 (-9.42, 1.37) -7.40 (-14.66,-0.15) 0.14
H19 CTCF3 -1.63 (-5.29, 2.02) -1.84 (-5.95, 2.27) -4.72 (-9.41,-0.03) 0.37
H19 CTCF6 -3.52 (-8.37, 1.33) -0.77 (-7.57, 6.02) -5.16 (-12.33, 2.00) 0.30
IGF2DMR0 0.17 (-2.86, 3.19) 0.57 (-2.64, 3.78) -1.34 (-5.93, 3.26) 0.82
IGF2R 0.76 (-1.80, 3.32) 1.31 (-0.94, 3.55) -3.64 (-10.24, 2.95) 0.54
a Infertility diagnoses were divided into the following groups: Female factors (Female) n = 21, Male factors (Male) n = 17, Both male and female factors (Both) n
= 16, and Unexplained (Unexp) n = 6
b Adjusted for pyrosequencing run, child’s age, child’s birth weight, child’s sex, maternal age, maternal education, and household income
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Author Tissue ART group SC group Gene/Region Findings
Oliver, et
al. [38]
Blood 66 (34 IVF, 32 ICSI) 59 H19, KCNQ1OT1,
SNRPN, IGF2,
LOC388665, INSL5, ARHGAP24,
STK19, NCRNA00282, JPH4,
SYP, BEX1
Only significant difference in
NCRNA00282 and possibly
ARHGAP24
Zheng, et
al. [36]
Cord blood 101 (40 ICSI, 61 IVF) 60 KvDMR1, SNRPN,
MEST, MEG3, TNDM,
XIST
All showed normal
methylation
patterns
Zheng, et
al. [37]
Chorionic villus
samples
44 spontaneous
abortions, 22
multifetal reductions
45 spontaneous
abortions, 47
induced abortions
PEG1/MEST Higher methylation in
spontaneous abortions in
ART or SC group
compared with other two
groups,
no difference between ART
and
SC
Wong, et
al. [34]
Placenta 77 (32 IVF, 45 ICSI) 12 H19/IGF2 ICR1 No difference between
groups
consisting of IVF, ICSI, SC
stratified by size for
gestational
age, 6 ART and 2 SC cases
with hypomethylation
Shi, et al.
[31]
Cord blood 61 30 IGF2/H19 ICR No difference between
groups, but
three ICSI children had
abnormal demethylation
Li, et al.
[28]
Cord blood 29 twin pairs 30 twin pairs KvDMR1, PEG1,
H19/IGF2 DMR
No significant differences,
but
lower methylation in
KvDMR1 and
higher methylation in H19/
IGF2 in
ART twins.
Zechner,
et al. [35]
Chorionic villus
samples
42 spontaneous
miscarriages and
stillbirths
29 abortions and
stillbirths
H19, MEG3, LIT1,
MEST, NESP55, PEG3,
SNRPN, NANOG, APC
No significant difference
between
groups, more extreme
methylation
values in the control group
Turan, et
al. [33]
Cord blood, cord,
placenta
45 56 IGF2/H19, IGF2R The maternal to paternal
methylation ratio mean and
variance were greater in the
IVF
group for both tissues
(means in
cord and placenta and
variance in
cord blood and cord), no
differences for IGF2R
Tierling, et
al. [32]
Maternal blood, cord
blood, amnion/
chorion tissue
112 (77 ICSI, 35 IVF) 73 KvDMR1, H19,
SNRPN, MEST, GRB10, DLK1/MEG3,
Ig-DMR, GNAS NESP55, GNAS
NESPas, GNAS XL-
alpha-s, GNAS Exon1A
Difference in MEST in cord
blood
(IVF vs. ICSI or IVF vs. SC),
higher MEST methylation in
IVF
mothers vs ICSI or SC; also
possible differences in
DLK1/MEG3 and the GNAS
region
in cord blood
Chen, et
al. [23]
Embryos 32 0 H19 DMR 18.7% with hypomethylation
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found a statistically significant difference between
groups [25,26,28,31,32,34,35,38].
For the KvDMR region, some expression differences
have been seen in placenta for CDKN1C,b u tn o t
KCNQ1OT1 [30]. Other studies have found no differ-
ences within this region [27,32,35,36], although one did
note hypomethylation in three children conceived
through ART [24] and another found hypermethylation
of KCNQ1OT1 in a child conceived using ART [25]. As
with the IGF2/H19 region while there is some evidence
of possible hypomethylation [24,27,28,35], most studies
have not found a statistically significant difference
[24,26,28,32,36,38].
Two regions examined in this study are relatively
novel, having only been examined in one prior study.
The DMR in the IGF2R gene is of particular interest
since it has not be well studied, and a recent study asso-
ciated gain of methylation at this locus with growth
restriction [42]. We found a non-significant decrease in
methylation within the IGF2R region for both lympho-
cyte and buccal cell samples, which would be in contrast
to the growth restriction study, since children conceived
through ART tend to be smaller at birth [43]. The only
other study examining this locus in children conceived
through ART also did not find a difference in DNA
methylation in cord blood, cord samples, or placenta,
but quantitative results are difficult to compare since
that study used the ratio of maternal to paternal allele
methylation as their primary outcome [33]. The IGF2
DMR0 was only recently examined in a study by Oliver,
et al., who found no difference in DNA methylation at
this region in peripheral blood samples [38]. While our
s t u d yc o n c u r sw i t ht h e s ef i n d i n gf o rp e r i p h e r a lb l o o d ,
we did find non-significant increase in DNA methylation
at this region in buccal cells of children conceived
through ART, so small differences in DNA methylation
cannot be ruled out for this locus.
Another study used a methylation bead-array platform
and examined 1536 CpG sites in over 700 genes using
placenta and cord blood samples and found an overall
lower level of methylation at CpG sites in the placenta
samples of in vitro conceived children and a higher level
of methylation in cord blood of in vitro conceived chil-
dren [26]. This study also found many individual genes
that had differential methylation between the two
groups. However, none of the genes analyzed in our
study were specifically identified.
Other regions that have been explored in multiple stu-
dies include SNRPN, MEG1/GTL2, PEG1/MEST,a n d
PEG3. No studies have found evidence of a difference in
DNA methylation in the SNRPN region in children
Table 4 Summary of previous studies examining DNA methylation differences in ART conceptions (Continued)
Kobayashi,
et al. [27]
Trophoblastic villi 78 abortions 38 non-ART
abortions
H19, GTL2, PEG1, KCNQ1OT1, ZAC,
PEG3, SNRPN
Hypomethylation in ART
cases
relative to controls for H19
(n = 6),
GTL2 (n = 2), PEG1(n = 1),
LIT1
(n = 4), ZAC (n = 1), PEG3 (n
=1 )
Katari, et
al. [26]
Cord blood, placenta 10 13 Genome wide, 736
genes
Differentially methylated
CpG
sites tended to have higher
methylation in cord blood
and
lower methylation in
placenta
Kanber, et
al. [25]
Buccal cells 19 small for
gestational age and
ICSI
29 normal birth
weight
KCNQ10T1, IGF2/H19, PEG1,
PEG3, PLAGL1, GTL2
1 ICSI child with
hypermethylation of
KCNQ1OT1
and PEG1, 2 control children
had hypermethylation of
GTL2
Gomes, et
al. [24]
Peripheral blood,
Cord blood, placenta
12 peripheral blood, 6
cord blood, placenta
22 peripheral blood,
8 cord blood,
placenta
KvDMR1 3 ART children with
hypomethylation in blood,
lower
levels in ART vs. SC, but not
statistically significant
Palermo,
et al. [30]
Blood 55 0 SNRPN No differences from
expected
Manning,
et al. [29]
Blood 92 ICSI Reference sample SNRPN No differences from
expected
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[26,27,29,30,32,35,36,38]. Differences have also not been
observed for the MEG1/GTL2 region in multiple studies
[25,26,32,35,36]. Methylation differences were found
between the ART and SC group in CpG sites associated
with the PEG1/MEST region in both cord blood and
placenta [26]. A second study support this finding, but
also found differences in methylation in maternal blood,
suggesting that the pattern seen in offspring was not
due to the infertility treatment [32]. Other studies have
not found a quantitative difference [28,35,37]; however
one study found a case of hypermethylation in buccal
cells [25] and one found a case of hypomethylation in
extra-embryonic tissue [27]. PEG3 was also identified as
have different methylation patterns between the ART
and SC group from the genome-wide study both in cord
blood and placenta [26], but other studies have not con-
firmed this finding [25,35]. One study found evidence of
h y p o m e t h y l a t i o ni no n eA R Tc a s ei nt h i sr e g i o n[ 2 7 ] .
Other regions have been identified in single studies, but
have not been confirmed.
The current study adds to the growing body of litera-
ture examining methylation differences in non-syndro-
mic children conceived through ART and children
conceived spontaneously. This study explored several
specific loci associated with growth, cancer, and BWS
some of which have been rarely studied in this popula-
tion. Using a quantitative measure of DNA methylation
is sensitive to detect subtle differences between groups
which may influence transcription and gene expression
[26]. It also included two sample types easily available
after birth to permit broad follow-up studies. Finally,
even though our sample size was not large, it is unlikely
that we missed substantial differences in methylation
based on our confidence intervals.
There are several caveats that should be addressed in
this study. First, methylation abnormalities such as the
t y p ew ea r el o o k i n gf o rh e r ec o u l db et i s s u es p e c i f i c
rather than a global phenomenon. While it would be
interesting to examine othert i s s u e s ,i tw o u l dn o tb e
ethical to obtain other tissue/sample types in otherwise
healthy children since most collection procedures would
be invasive. Unexposed individuals were a convenience
sample rather than a random sample from a particular
population. Women who use ART are more likely to be
white, have higher incomes, and be better educated
compared to infertile women who choose other or no
treatment [44]. Although we observed some demo-
graphic differences between the ART and SC groups,
mothers in the SC group were more likely to be white
and have higher income and education levels compared
to the US population and thus may represent a good
comparison group. Finally, a limited number of genetic
loci were evaluated in this study. Only those with the
most a priori likelihood of an association were examined
to maximize the potential for finding important
associations.
Conclusions
Overall, very small differences were observed in methy-
lation level at all loci between groups. Some possible
but non-significant differences in buccal cells and possi-
ble differences by infertility diagnosis may warrant addi-
tional follow up in other studies. The bulk of studies
performed so far indicate that large differences in
methylation are unlikely. However, it is not known the
potential biological effect that small differences in
methylation could have and there is some evidence that
these might be relevant. Although results of this study
are reassuring, additional large studies that include a
broad range of genes as well as long term follow-up of
children conceived through ART are needed to fully
assess possible epigenetic differences and the potential
impact of small differences on future disease in this
population.
Additional material
Additional file 2: Intraclass correlation coefficients for individual
CpG sites. Description: Table of the intraclass correlation coefficients for
the reliability analysis for the individual CpG sites.
Additional file 1: Detailed summary of the literature on DNA
methylation in children after ART. Two tables are included providing
qualitative (hypomethylation or hypermethyation) and quantitative
methylation differences between children conceived through ART and
those conceived spontaneously. One table presents the data for studies
examining blood or buccal cells and the other presents the same data
for extra-embryonic tissues.
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